Filing Flows

Filing Flows › Companies › Jaguar Health › Cash flow

Jaguar Health cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$5.3M in Q2 2026 · −$6.7M over twelve months

Operating cash flow−$5.3M
Free cash flow−$5.3M
Cash conversion cycle240 days

Analysis

In Q2 2026, Jaguar Health generated −$5.3M of operating cash flow. That is $857K more than in Q2 2025 (−$6.2M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$6.7M; the largest uses were operating cash flow ($6.7M); besides operations, cash came from other financing ($11.3M); the cash balance rose by $4.4M.

Operating cash flow was −$5.3M against net income of −$12.8M. The largest differences: accrued liabilities +$938K, inventory +$503K, depreciation & amortization +$473K.

Its cash conversion cycle was 240 days (receivables 3 + inventory 668 − payables 430).

Free cash flow

Jaguar Health: free cash flow by quarterJaguar Health: free cash flow by quarter−$6.3MQ3 2024−$7.8MQ4 2024−$7.3MQ1 2025−$6.2MQ2 2025−$4.7MQ3 2025−$5.5MQ4 2025$8.8MQ1 2026−$5.3MQ2 2026
Operating cash flow less capital spending.
Jaguar Health: operating cash flow against capital spendingJaguar Health: operating cash flow against capital spendingOperating cash flowCapital spending−$6.3M$0Q3 2024−$7.8M$0Q4 2024−$7.3M$0Q1 2025−$6.2M$0Q2 2025−$4.7M$0Q3 2025−$5.5M$0Q4 2025$8.8M$0Q1 2026−$5.3M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$5.3M, Capital spending $0.

Capital allocation, year by year

Jaguar Health: where the cash came from (up) and went (down), by fiscal yearJaguar Health: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2021: Operating cash flow −$35.0MFY2021: Net borrowing $10.9MFY2021: Shares issued $3KFY2021: Capital spending −$6K$10.9MFY2021FY2022: Operating cash flow −$33.1MFY2022: Net borrowing $4.0MFY2022: Capital spending −$77K$4.0MFY2022FY2023: Operating cash flow −$33.2MFY2023: Shares issued $611K$611KFY2023FY2024: Operating cash flow −$29.4MFY2024: Capital spending −$16KFY2024FY2025: Operating cash flow −$23.7MFY2025: Net borrowing $3.4MFY2025: Shares issued $2.4M$5.8MFY2025
Over these 5 years operating cash flow totalled −$154M; the largest uses were operating cash flow ($154M) and capital spending ($99K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$3.8M
Debtnone
Net cash$3.8M
Cash runway7 months

Jaguar Health is burning cash: its operations consume cash, a free cash flow of −$6.7M a year at the current rate against $3.8M of cash and investments: a runway of about 7 months before any new financing.

Where the cash came from and went

Jaguar Health: sources (+) and uses (−) of cash, Q2 2026Jaguar Health: sources (+) and uses (−) of cash, Q2 2026Operating cash flow−$5.3MCash drawn (+) / kept (−)$3.5MOther financing$1.9MExchange rates$2K
Jaguar Health: sources (+) and uses (−) of cash, TTM to Q2 2026Jaguar Health: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$11.3MOperating cash flow−$6.7MCash drawn (+) / kept (−)−$4.4MExchange rates−$187KNot reconciled−$41K

From profit to cash

Jaguar Health: net income to operating cash flow, Q2 2026Jaguar Health: net income to operating cash flow, Q2 2026Net income−$12.8MDepreciation & amortization$473KStock-based pay$171KReceivables$60KInventory$503KPayables−$138KAccrued liabilities$938KDeferred revenue−$42KPrepaid and other assets−$140KOperating cash flow−$5.3M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 20263668430240
Q1 20264638530111
Q4 20254240235886
Q3 20253918461302583
Q2 20253718371178695
Q1 20255618261076806
Q4 2024361653812877
Q3 2024381635735938

Every quarter

QuarterOperating cash flowNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q2 2026−$5.3M—$3.5M−$5.3M
Q1 2026$8.8M—−$2.2M$8.8M
Q4 2025−$5.5M—−$4.3M−$5.5M
Q3 2025−$4.7M—−$1.3M−$4.7M
Q2 2025−$6.2M−$3K$3.5M−$6.2M
Q1 2025−$7.3M$3.4M$2.3M−$7.3M
Q4 2024−$7.8M—$5.3M−$7.8M
Q3 2024−$6.3M—$2.8M−$6.3M

Jaguar Health: income statement and cash flow

Jaguar Health, Q2 2026: revenue $1.2M (-59% year over year), operating margin -620.2%. The chart follows the revenue to costs, profit and cash.

Jaguar Health: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.